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Cardiovascular diseases (CVDs) have been the leading causes of hospital admissions in 
Tanzania. Hypertension (HTN) and coronary artery diseases (CHD) are two most common 
CVDs frequently diagnosed causes of deaths in Tanzanian hospitals. This hospital based-
cross-sectional study conducted to assess lifestyle risk factors and levels of biomarkers for 
CVDs in patients with HTN and CHD attending cardiac clinic at Kilimanjaro Christian 
Medical Centre-referral hospital. Structured questionnaire was used to assess socio-
demographic characteristics and lifestyle risk factors, while anthropometric measurements 
were taken to assess nutritional status of patients. Blood samples were collected from each 
patient and analyzed by Cobas Integra and Maglumi analyzers, to detect and quantify 
concentration of biomarkers. Descriptive statistics were used to analyze socio-demographic, 
lifestyle risk factors and studied biomarkers for CVDs. Pearson’s Chi-Square (χ
2
) tests were 
used to associate risk factors for HTN and CHD while multinomial logistic regression was 
used to determine independent predictors of HTN and CHD. Majority of the patients (65%) 
were diagnosed with HTN, and 35% with CHD. The most prevalent risk factors for HTN and 
CHD were: alcohol intake (67%), high blood pressure (59%), physical inactivity (61%), 
obesity (39%), alanine aminotransferase (43%), high-density lipoprotein (79%), low-density 
lipoprotein (65%), C-reactive protein (78%), sodium (41%) and potassium (40%). Moreover, 
age (p = 0.007, CI = 0.047-0.612), plasma glucose (p = 0.016, CI = 0.62-0.76), alanine 
aminotransferase (p = 0.035, CI = 0.12-0.93), and C-reactive protein (p = 0.018, CI = 0.08-
0.79) were independently associated with HTN and CHD. The study affirmed higher 
exposure of patients to CVDs risk factors despite them being under medical management. 
The results herein call for sensitization programs, to include more interventions, such as 
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1.1 Background information 
Cardiovascular diseases (CVDs) are diseases of heart or blood vessels that include coronary 
artery disease/coronary heart diseases (CAD/CHD), cerebrovascular diseases and peripheral 
artery diseases (WHO, 2008). Currently, CVDs are regarded as the major cause of overall 
world mortality and morbidity (Haines et al., 1992), and substantially contribute to the 
escalating costs of health care (Ngaleison et al., 2017). More than 17.92 million people died 
in 2015 due to CVDs, with highest death rate of 9.4 million recorded in men and 8.5 million 
in women, respectively (WHO, 2017a). There is a growing trend of CVD mortality from 16.7 
million deaths in 2002 to 17.92 million deaths in 2015, and this is also projected to take lives 
of 23 million people by 2030 if no measure will be taken to alleviate the problem (Mathers 
and Loncar, 2005; WHO, 2011; Roth et al., 2017; WHO, 2017). Surprisingly, more than 80% 
of the deaths from CVDs occur in low-middle income countries and is affecting more than 
37% of the aged ≤ 70 years old people (Fuster, 2014; Roth et al., 2017; Keates et al., 2017). 
More than 40% of premature CVD deaths occurred in low and middle income countries in 
2011 and only 4% in high income countries (WHO, 2011). Moreover, CVDs are causing 
more than 20 million deaths in the African region, with the smallest deaths rates (8.8%) 
documented in the sub-Saharan region (Moran et al., 2014). 
Among all types of CVDs, coronary heart diseases (CHDs) are the leading cause of deaths 
across all the world regions (WHO, 2011; Gaziono et al., 2011; Onen, 2013; Roth et al., 
2015). Of all CVD deaths that occurred in 2015, CHD ranks as the highest cause of deaths, 
accounting for more than 8.9 million deaths worldwide (Roth et al., 2017). Furthermore, the 
global projection of mortality and diseases burden predict that world mortality rates due to  
CHDs will rise by 13.3% in 2015 to 14.1% by 2030 (Mathers and Loncar, 2005). Coronary 
heart diseases will rise by 70% in men and 74% in women in African regions if there will be 
no implementation of urgent prevention interventions (Onen, 2013).  
The prevalence of CHDs is increasingly uneven in different regions of the world, due to 
inadequate and poor healthcare services (Gaziono et al., 2011). Both in developed and 
developing countries, CHDs are considered as a single cause of mortality and morbidity 
across all gender (Gaziono et al., 2011). Coronary heart diseases were considered to be 




however, CHDs are reported to have a significant effect in recent years, with high death rates 
being reported in the region (Ebireri et al., 2016).  
The growing mortality rates due to CHD are highly influenced by the increased levels of 
blood pressure/hypertension (HTN). Hypertension is one of the leading risk factors for global 
mortality (accounting for 13% of the total deaths) (WHO, 2009), attributing to more than 
45% of all CHD deaths and 51% deaths due to stroke worldwide (WHO, 2013). Untreated 
HTN results to more health complications, such as myocardial infarction, renal diseases, 
stoke, heart failure and premature deaths (WHO, 2013), which later increase the cost of 
treatment and management (Ngalesoni et al., 2015). Treatment of high blood pressure has 
been associated with a reduction of more than 40% and 16% risks of stroke and myocardial 
infarction, respectively (Reamy et al., 2007).  
The ultimate goal for managing HTN is to achieve target control and prevent the 
development of other hypertension-related complications (Ross, 2017). As a rule of thumb, 
the World Health Organization and the International Society for Hypertension recommend 
management of HTN by monitoring other CVD risk factors, patient-centred lifestyle 
modification, organ damage and their related clinical signs (WHO/ISH, 2003; WHO, 2014a), 
rather than relying on taking blood pressure measurement alone. However, the management 
of hypertension and hypertension related-diseases, including CHDs, usually vary from one 
country to another as it depends on the country capacity to utilize the available resources for 
prevention and control of diseases (WHO/ISH, 2003). In high income countries, there is 
significant reduction of HTN and other CVDs, due to implementation of wide population 
interventions and strong public policies, such as salt intake reduction, widely accessible 
diagnosis and treatment methods for HTN, and other risk factors. These have resulted to a 
50% reduction of CVD mortality rate in these countries (Danaei et al., 2011). Contrary, CVD 
risk factors and related diseases seem to increase in developing countries, where there is large 
number of people suffering from heart attack and stroke due to undiagnosed and uncontrolled 
CVD risk factors such as HTN (WHO, 2013).  
Addressing lifestyle risk factors by raising awareness on healthy eating, regular physical 
activity, avoiding smoking and alcohol intakes can therefore prevent HTN and hypertension-
related diseases (WHO, 2013). Management of lifestyle and intermediate risk factors for 




blood pressure in patients with HTN, and may sometimes also reduce the need for 
antihypertensive therapy to patients (Anderson et al., 2016; Cléroux et al., 1999). 
Regardless of the growing burden of HTN, CHD and their associated risk factors among 
patients, information on treatment and management progress is insufficient in most of the 
sub-Saharan countries including Tanzania (Escobar, 2002). The focus of this study was 
therefore to assess lifestyle risk factors and respective biomarkers (serum lipids, alanine 
aminotransferase, C-reactive protein, plasma glucose, sodium, and potassium levels) and 
nutritional status among patients with CVDs attending cardiac clinic at Kilimanjaro Christian 
Medical Centre referral hospital. These risk factors were then associated with HTN and CHD. 
Findings from this study will help to improve diagnostic methods, planning, designing and 
implementing the best preventive interventions.  
1.2 Problem statement 
Tanzania, like any other developing country, is facing a high burden of non-communicable 
diseases (NCDs) (Mayige et al., 2012). Non-communicable diseases are affecting 33% of all 
adults aged 25-64 years in Tanzania, with CVDs accounting for 13% of all deaths (WHO, 
2016b). The trend of CVDs in Tanzania among adults aged ≥ 25 years raised from 9%-13% 
between 2012 and 2016 (WHO, 2014b; WHO, 2016), probably due to the higher prevalence 
of CVD risk factors (Mayige and Kagaruki, 2013). In the past two decades, CVDs especially 
CHD, were considered to be uncommon in Tanzania (Kitange et al., 1993; Swai et al.,1993). 
However, findings from current studies showed higher prevalence of these diseases in 
Tanzania (Edwards et al., 2000; Makubi et al., 2014; Galson et al., 2017). The rates of CVD 
cases attending Tanzanian hospitals is increasing, posing huge challenges in their treatment 
and management in primary and secondary healthcare facilities, due to inadequate health care 
resources (Ngalesoni et al., 2015).  
Hypertension and coronary heart diseases are the two most frequently diagnosed CVDs 
among patients in Tanzanian hospitals (Kisenge, 2011; Peck, 2013; Peck et al., 2014). 
Hospital-based studies conducted in Tanzania have revealed higher prevalence of HTN and 
CHD as major public health concerns (Kisenge, 2011). For example, hypertension-related 
diseases account for 34% of all NCDs deaths, 30% of admission and 28% of all hospital days 
at Bugando referral hospital from 2009 to 2011 (Peck, 2013). Moreover, Makubi et al. (2014) 




three years prospective heart failure study conducted at Muhimbili National Hospital from 
2012-2013. The growing rates of HTN and CHD observed in Tanzania hospital is highly 
influenced by the low rate of treatment and poor control of the diseases and their associated 
risk factors (Peck et al., 2014). A study conducted by Dewhurst et al. (2013), observed that, 
among patients with HTN, only one-sixth (16%) of the patients were under the management 
of HTN.  
 Despite the growing burden of these diseases in Tanzanian hospitals, current management 
practice is highly based on measurements of few risk factors, especially control of blood 
pressure, blood cholesterol and blood sugar (Makubi et al., 2014). Management of 
intermediate risk factors should not be monitored alone, but it should include assessment of 
all other CVD risk factors in a holistic approach, by incorporating patient-centered lifestyle 
modification (WHO/ISH, 2003). Regular monitoring of lifestyle risk factors, together with 
intermediate risk factors for HTN and CHD among patients attending cardiac clinics, is an 
integral part of diseases management, due to its implications on treatment outcomes (WHO, 
2013; WHO, 2014a). Proper management of the diseases by addressing all CVD risk factors 
have significantly contributed to the reduction and prevention of HTN and CHD related 
mortality (WHO/ISH, 2003). To date, no study had been conducted in Tanzanian hospital settings 
to evaluate CVD risk factors among patients attending cardiac clinics, to see how they respond to 
current treatment. Therefore, this study evaluated lifestyle risk factors, 
intermediate/biomarkers for CVD and their association with HTN and CHD among patients 
attending a cardiac clinic at KCMC referral hospital in Tanzania.  
1.3 Rationale for the study  
Determination of most common CVD risks factors, among patients attending cardiac clinic 
will provide an opportunity for better intervention, prevention and treatment 
outcome/prognosis. To the best of our knowledge, no study has been conducted in the 
proposed study area (Kilimanjaro) on associated markers for CVDs, despite presence of 
research findings that the prevalence of CVD is higher in Kilimanjaro region compared to 
other regions of Tanzania (Galson et al., 2017). Moreover, most hospital-based studies 
conducted in Tanzania have always involved a few CVD risk factors (which are known), but 
no study had been conducted to evaluate the studied risk factors among patients attending 





1.4 Aim of the study  
1.4.1 General objective  
The main objective of this study was to assess lifestyle risk factors for CVDS among patients 
with hypertension and coronary heart diseases at KCMC referral hospital in Tanzania.  
1.4.2 Specific objectives  
(i) To determine lifestyle risk factors among patients with hypertension and coronary 
artery diseases attending the cardiac clinic at Kilimanjaro Christian Medical Centre- a 
referral hospital. 
(ii) To determine blood pressure and nutritional status of patients with hypertension and 
coronary heart diseases. 
(iii) To determine the levels of intermediate risk factors/biomarkers (LDL, HDL, ALT, 
CRP, blood glucose and Na/K) among patients with hypertension and coronary heart 
diseases.   
(iv) To determine the association between studied lifestyle risk factors, their biomarkers, 
and socio-demographic characteristics among patients with hypertension and 
coronary heart diseases attending cardiac clinic at Kilimanjaro Christian Medical 
Centre-a referral hospital. 
1.5 Research questions  
(i) What are the lifestyle risk factors in patients with hypertension and coronary heart 
diseases attending KCMC?  
(ii) What are the nutritional status and blood pressure levels among the studied patients? 
(iii) What are the levels of LDL-C, HDL-C, ALT, CRP, blood glucose and Na/K levels 
among patients with Hypertension and CHD? 
(iv) How LDL and HDL, ALT, CRP, blood glucose Na/K levels, nutritional status, and 






 LITERATURE REVIEW 
2.1 Overview of hypertension and coronary heart diseases  
Hypertension accounts for 13% of all deaths globally (Alwan and Armstrong, 2011) and 
HTN is responsible for 9.4 million deaths each year (WHO, 2013). Worldwide, HTN has 
attributed to 45% and 51% deaths due to ischemic heart diseases and strokes, respectively 
(WHO, 2009). Nearly 22% of the world adults in 2014 (> 18 years) were hypertensive 
(WHO, 2014a). Furthermore, the African region represents higher (46%) prevalence of 
hypertension compared to high-income countries (35%) (WHO, 2013). According to global 
projections of diseases, high blood pressure (> 115 mmHg) is estimated to cause 49% of 
CHD and 62% of stroke deaths (Mackay and Mensah, 2004) if no measures will be taken to 
alleviate the condition. 
The current national STEP survey (2012) showed that 26% of all Tanzanian adults aged 25 to 
64 years were hypertensive (Mayige and Kagaruki, 2013). Prevalence of hypertension differs 
from one region to another and from rural to urban areas. Prevalence of HTN was reported to 
be 19% in rural areas (32.2% in men and 31.5% in women) and 35% in urban areas (30% in 
men and 28.6% in women) (Edwards et al., 2000). This might be influenced by sedentary 
lifestyle and dietary variations for rural to urban dwellers, which include consumption of 
highly processed food, high salt intake, low consumption of fruits and vegetables. 
Hypertension is also influenced by high rates of overweight and obesity, that are more 
prevalent in the urban (Bovet et al., 2002; Njelekela et al., 2009). Similar related studies 
conducted in different regions of Tanzania also reported a higher prevalence of HTN. For 
example, prevalence of 21.3% among adults aged ≥ 35 years was reported in Manyara among 
Maasai in 2015 (Mandha et al., 2015), 23.7% in Dar es Salaam (Hendriks et al., 2012), 28% 
in Kilimanjaro region (Galson et al., 2017), and 44.2% in Mwanza (Mosha et al., 2017). Few 
hospital-based studies conducted in the country have also shown an increased number of 
hypertension cases in hospitals (Kisenge, 2011; Peck et al., 2014).   
2.2 Pathophysiology of coronary artery disease and hypertension 
Pathophysiology of CVDs affects coronary, cerebral or peripheral arteries, and share similar 
mechanisms that involve atherosclerosis and thrombosis (or clotting). Hypertension is a main 




through formation of atherosclerotic plaque in large and medium arteries. Atherosclerosis 
involves deposition of cholesterols from LDL-C, calcium, inflammatory biomarkers, such as 
CRP, Liver enzymes such ALT, alanine glyoxylate aminotransferase (AGT) and fibrin 
(Escobar, 2002; Baguet and Mallion, 2005; Amani and Sharifi, 2005). Reduction in diameter 
of the coronary arteries by atherosclerotic plaques promotes decreased coronary reserves and 
myocardial oxygen demand (Escobar, 2002). Over time the unstable plaque eventually 
ruptures and forms thrombus, which occludes the flow of blood in some parts of the heart, 
hence causing acute coronary syndromes that result in myocardial ischemia (Baguet and 
Mallion, 2005).  
2.3 Factors that influence development of coronary artery diseases and hypertension 
The two diseases, hypertension and CHD have a strong association and share similar risk 
factors and common pathophysiology (Milane et al., 2014; Weber et al., 2016). Risk factors 
for the development of HTN and CHD are categorized into non-lifestyle risk factors (age, 
genetics/ family history), lifestyle risk factors (unhealthy eating, smoking, physical inactivity 
and alcohol intakes), and intermediate risk factors (raised blood pressure, raised blood 
cholesterol, diabetes, overweight and obesity). Rapid epidemiological transition and 
urbanization have been associated with a higher prevalence of these risk factors (Mbewu, 
2009; Onen, 2013; Dewhurst and Walker, 2016; Cappuccio and Miller, 2016). Such risk 
factors have been attributed in causing more than 90% of all deaths occurring in African 
countries, including Tanzania, and have been linked to socio-economic status and inadequate 
health services offered in primary and secondary healthcare facilities (Steyn et al., 2005; 
Belue et al., 2009). 
 2.3.1 Lifestyle risk factors 
Lifestyle/behavioral risk factors are the most common preventable risk factors that underlie 
the development of CVDs (WHO, 2011). These include unhealthy eating, tobacco use, 
excessive alcohol intake and physical inactivity. Poor management and prevention of these 
risk factors can result in metabolic/physiological changes that lead to the development of 
CVDs (WHO, 2014).  
(i) Smoking 
Smoking is the leading preventable risk factor for cardiovascular diseases such as ischemic 




Wambura and Jamal, 2012). Chemicals present in tobacco (tar, carbon dioxide and nicotine) 
are associated with increased risk of heart diseases. Nicotine is associated with increased 
blood pressure and heart rate (Shamshad, 2014). Tar causes damage to the blood vessels and 
create adverse lipid profile that thicken the blood vessels while carbon dioxide reduces 
affinity of oxygen to the heart muscles (Shamshad, 2014), causing myocardial infarction. All 
these contribute to the formation of atherosclerosis and causing a mismatch between the 
demand and supply for myocardial oxygen and blood to the heart (World heart Federation, 
2018).  
Worldwide, nearly one billion peoples are current smokers (WHO, 2011a), with more than 
seven million people dying each year from smoking-related diseases (WHO, 2017c). Of all 
deaths, 6 million deaths resulted from direct smokers and 890000 deaths from non-
smoker/second hand smokers in 2010 (WHO, 2011; WHO, 2017b). According to WHO 
estimates, annual tobacco-related deaths are anticipated to rise to 8 million by 2030, 
accounting for 10% of all deaths globally if no appropriate measures will be taken to stop 
smoking (WHO, 2011b). More than three-quarter of smokers live in low and middle-income 
countries where the burden of tobacco-related diseases and deaths is also high (WHO, 
2017c). For example, the prevalence of tobacco and cigarette smoking among adults in 
Tanzania is 14.1% for current tobacco smokers, 11.8% for daily tobacco smokers and 9.4% 
for daily cigarette smokers (WHO, 2017b). Within the country, smoking prevalence also 
varies from one part of the country to another. Cigarette smoking is very common in 
Southern zone (31%) and least common in Southern highlands (12%), and this is highly 
influenced by the low level of education and poor economic status (Kapito-tembo, 2011). 
Another study conducted in Tanzania by Kidane et al. (2015) reported a high prevalence of 
smoking-related diseases of 41.3% and 8.5% among men and women, respectively. Cessation 
of tobacco and cigarette smoking has proven to have immediate and long term benefits. The 
risk for coronary heart disease is about half that of smokers risk after one year of quitting 
from smoking, and the risk for coronary heart disease is that of a non-smoker after 15 years 
(World heart Federation, 2018). Health care professionals should therefore actively advice 
and help patients visiting cardiac clinic to quit from tobacco and cigarette smoking. 
(ii) Alcohol consumption 
Excessive alcohol consumption is a risk factor for multiple adverse social and health 




developing various chronic diseases, such as non-communicable diseases, mental and 
behavioral disorders (WHO, 2014a). The amount of pure alcohol consumption was 
approximately 6.2 liters per person aged ≥ 15 years globally in 2010 (WHO, 2014b). Average 
pure alcohol consumption was estimated to be 7.7 liters per person aged ≥ 15 years in 
Tanzania, which is greater than that of global estimates (WHO, 2014c). Excessive alcohol use 
is accounting for 3.3 million of the total deaths worldwide (WHO, 2010) and of these deaths, 
NCDs, especially CVDs and diabetes account for 33.4% (WHO, 2014a). Excessive alcohol 
consumption increases the CVD risks as it damages the heart muscles, causing increased 
blood pressure, raised blood cholesterol, increased fibrinolysis and promotion of cardiac 
arrhythmia (Mukamal, 1995; WHO, 2011). Excessive alcohol intake increases the risk for 
NCDs, although in large meta-analyses of observational studies regular to light alcohol 
consumption seems to confer protective effects on coronary heart disease and ischemic stroke 
(Higashiyama et al., 2013; Bardach, 2017). However, one of the latest Lancet journals has 
reported that there is no safe level of alcohol intake, any amount of alcohol is linked to 
increased mortality from NCDs and all other diseases including road traffic accidents (Burton 
and Sheron, 2018). 
(iii) Physical activity 
Nearly 3.2 million people die from insufficient physical activity each year (WHO, 2011b), 
with highest death rates marked in women (27%) than in men (20%) (WHO, 2014a). People 
who engage in physical activity are at lower risk for developing and dying from chronic 
diseases such as NCDs, including CHD (WHO, 2014). Physically inactive people have 20-
30% increased the risk of dying from NCDs compared to physically active people (WHO, 
2011b). Low levels of physical activity have been associated with increased CVD risk 
(Dickie et al., 2014), therefore meeting WHO recommended level of physical activity help to 
prevent CVD risk factors, such as overweight and obesity, which in turn reduce waist 
circumference, blood cholesterol, vascular inflammation, finally improving endothelial 
dysfunction, insulin sensitivity and endogenous fibrinolysis (WHO, 2011; Mashili et al., 
2018). Regular physical activity has been proven to reduce risks for CHD by half, helping to 
prevent stroke and diabetes type 2 (Cléroux et al., 1999; Press et al., 2003).  
The level of physical activity varies from rural to urban settings in Tanzania, probably due to 
various types of work performed by the people in these areas. Higher levels of physical 




Tanzania, respectively (Mbalilaki et al., 2007; Mashili et al., 2018). People living in rural 
areas have higher levels of physical activity compared to urban peoples as they engage in 
manual and physical works, such as walking a long distance and farming activities (Mandha 
et al., 2015). Strong evidence exists on the association between regular physical activity, 
HTN and CHD prevention (Cléroux et al., 1999). Regular physical activity is associated with 
a reduction of 3.2 mmHg and 2.7 mmHg systolic and diastolic blood pressure, respectively. 
However, for patients with poorly controlled HTN (systolic ≥ 180 mmHg and diastolic ≥ 100 
mmHg), physical exercise should be suspended until their blood pressure is stabilized. It is 
thus recommended to engage in any physical exercise rather than none (Anderson et al., 
2016; Cléroux et al., 1999). In order to improve the overall health and prognosis of patients 
with CHD, health professionals should therefore, focus more on cardiac rehabilitation and 
other interventions that help to maintain or increase exercise after CHD diagnosis.  
(iv) Unhealthy diet 
A healthy diet plays an important role in the prevention of NCDs such as CVDs (WHO, 
2016b). Higher consumption of saturated fat, trans-fatty acids, cholesterol and salty foods, 
with inadequate intake of fruits, vegetables and fish increase the risk for CVD, type 2 
diabetes, and cancers (WHO, 2008; WHO, 2010; Eilat-Adar, 2013; Awosan et al., 2014; 
WHO, 2016). Diet with an adequate amount of fruits and vegetables, mono-unsaturated and 
polyunsaturated fatty acids, and high in fibers reduces the risk for chronic diseases, including 
HTN and CHD (Karvonen, 1988).  
Globally, nearly 10% of the ischemic heart diseases deaths is attributed to inadequate 
consumption of fruits and vegetables, with most of the African countries experiencing the 
double burden of unhealthy eating and malnutrition (underweight and overweight) (WHO, 
2016b). On the other hand, higher consumption of salty foods and a diet rich in sodium is an 
important determinant of hypertension and CVDs (WHO, 2011; WHO, 2012; Tragni et al., 
2012). Excessive salt intake (more than 5 g per day) accounted for 1.7 million deaths due to 
CVD globally in 2010 (WHO, 2014). Based on WHO recommendations, reduction of salt 
intake to about 1 teaspoon per day help in the prevention of hypertension, heart disease and 
stroke (WHO, 2016a). A new health planetary diet has been recently by the Lancet Planet 
Food Commission, recommend a planetary diet rich in plant-based foods and with fewer 
animal source as it confers both improved health and environmental benefits. Furthermore, a 




the other half, displayed by contribution to calories, should consist of primarily whole grains, 
plant protein sources, unsaturated plant oils, and (optionally) modest amounts of animal 
sources of protein (Willett et al., 2019). 
2.3.2 Intermediate risk factors  
Intermediate risk factors have a direct link with the NCDs (WHO, 2011). These appear as the 
results of uncontrolled behavioral risk factors. The key intermediate risk factors for CVDs 
include: raised blood pressure, diabetes, raised blood cholesterol, overweight and obesity.   
(i) Overweight and obesity 
Overweight and obesity are among the leading causes of CVD mortality and morbidity  
(Ahmad, 2012). Overweight is defined as having body mass index (BMI) of 24.9-29.9 kg/m
2
 
and obesity as a BMI of greater or equal to 30 kg/m
2
 (WHO, 2012). Obese individuals have 
higher risk for diabetes, hypertension, hyperlipidemia, CHD, stroke and certain types of 
cancer than non-obese (Njelekela et al., 2009; WHO, 2014a). According to WHO estimates, 
overweight and obesity contribute to 2.6 million deaths from the global disease burden 
(WHO, 2011a). Both socio-demographic characteristics and economic factors have influence 
on the causation of overweight and obesity (Shayo and Mugusi, 2011). However, lack of 
enough statistics, together with socio-cultural beliefs, create greater challenges in 
understanding the trends of overweight and obesity as public health concerns in African 
countries including Tanzania (Pangani et al., 2016).  
Results from a multi-country cross-sectional study done in 2016 among four Sub-Saharan 
African countries showed a higher prevalence of overweight and obesity of 46% in rural 
Uganda, 48% in peri-urban Uganda, 68% in urban Nigeria, 75% in urban Tanzania and 85% 
in urban South Africa (Ajayi et al., 2016). Another study conducted in Dar es Salaam by 
Shayo and Mugusi (2011) reported a higher prevalence of obesity (19.2%) that was 
significantly more prevalent in women (24.7%) than men (9%). Individual perception of body 
weight is one of the factor that is contributing to the rise of overweight and obesity 
prevalence in Tanzania. Among individuals who participated in the study conducted by 
Muhihi et al. (2012), only 12% men and 25% women perceived their body weight as being 
obese compared to overweight, of which 22% men and 38% women perceived themselves as 
being overweight. Some studies provide evidence on the association between weight loss and 




cause mortality (Haines et al., 1992; Wing, 2011; Anderson et al., 2016). Weight loss of 5 to 
10% was associated with a 5 mmHg decrease in diastolic and systolic blood pressure, 5 
mg/dL increase in HDL cholesterol, and 40 mg/dL decrease in triglycerides in another 
observational analysis study (Wing, 2011). Moreover, evidence from meta-analysis study 
showed that reduction of 5.1 kg of body weight by means of energy restriction and increased 
physical activity reduces systolic and diastolic blood pressure by 4.4 mmHg and 3.6 mmHg, 
respectively (Neter et al., 2003). 
(ii) Hypertension  
High blood pressure has been acknowledged as one of the strongest risk factors for the 
development of CVD events, especially coronary heart disease and cerebrovascular diseases, 
later posing a huge challenge in treatment and management at individual and population level 
(Olafiranye et al., 2011; WHO, 2012; WHO, 2013). High blood pressure (systolic pressure ≥ 
140 mm/Hg and diastolic pressure ≥ 90 mmHg ) causes damage of blood vessels that results 
in increased risks for stroke, heart disease, kidney failure and other hypertension-related 
diseases (WHO, 2009). Symptoms for raised blood pressure are rarely seen at early stage, 
hence this may lead to undiagnosed cases and sometimes those who are diagnosed may not 
have access to treatment, hence increasing hypertension-related diseases to the community 
(WHO, 2013). Uncontrolled blood pressure can result to more health complications, such as 
heart diseases, renal diseases (Peck et al., 2014), diabetes (Basimaki, 2013), myocardial 
infarction, aneurysms, stroke, impaired insulin activities, and premature mortality and 
morbidity (WHO, 2005; WHO, 2013).   
Early detection, treatment and proper management of HTN provide significant health and 
economic gains to the population (WHO, 2014). Treatment of HTN and hypertension-related 
complications require costly interventions, such as cardiac bypass surgery, carotid artery 
surgery and dialysis, which in turn drain individual and government budgets (WHO, 2013). 
One of the cost-effective intervention towards control of blood pressure is through the 
implementation of a population-wide intervention that addresses all CVD risk factors as a 
recommended by WHO (WHO, 2014a). Furthermore, WHO recommends reduction of salt 
intake to > 5 g/day (2 g/day of sodium), to reduce blood pressure and the related risk for 





(iii) Raised blood cholesterol 
In 2008, 38% of the world population had higher blood cholesterol in 2008 (WHO, 2011a). 
About one-third of all global ischemic heart diseases are caused by higher blood cholesterol 
(WHO, 2009). The prevalence of raised blood cholesterol was highest (54%) in WHO 
European region and lowest (23%) in WHO African region in 2008 (WHO, 2009; WHO, 
2011a), and this was influenced by rapid urbanization and sedentary lifestyles. According to 
WHO estimates in 2010, nearly 20% of males and 24% of females in Tanzania had higher 
blood cholesterol (WHO, 2014b). Kilimanjaro region has been reported with the highest 
prevalence (17.4% of men and 19% of women) of raised cholesterol compared to Morogoro 
(5% of men and 6.7% of women), and Mara regions (4.8% of men and 6.9% of women) 
(Swai et al., 1993). Njelekela et al. (2009) reported higher prevalence (48%) of serum 
triglyceride among study participants, and this was associated with higher prevalence of 
overweight (33%) obesity (23%) and hypertension (57%).   
Diet rich in saturated fats, physical inactivity and genetic factors increase the risk for 
increased blood cholesterol (WHO, 2009). Higher levels of low-density lipoproteins and low 
levels of high-density lipoproteins increase the risk for heart diseases and stroke (Mathers and 
Loncar, 2005), since LDL-C are deposited on the walls of blood vessels, and causes 
atherosclerosis (WHO, 2011a). Every increase of 1 mmol/L of serum cholesterol is associated 
with a 40 to 80% increase in CHD risk factors in men (Fracp, 1999). Furthermore, poor 
dietary diversification contributes to increased blood cholesterol. Study findings showed that 
a lower intake of fruits and vegetables, with higher intake of red meat, have been linked to 
increased levels of blood cholesterol (Mandha et al., 2015). For example, higher intakes of 
coconut oil, palm oil, and meat showed an association with increased blood cholesterol 
(Njelekela et al., 2003; Katalambula et al., 2017). Lowering of blood cholesterol has been 
linked to reduced risk for heart disease. For example, a 10% reduction of blood cholesterol 
resulted in 50% reduction of heart diseases risks in five years follow up study (Woodward et 
al., 2007). Shifting from using saturated to unsaturated oil, encouraging people to eat at least 
five servings of fruits and vegetables per day can help to reduce blood cholesterol and CVDs.  
(iv) Diabetes  
Diabetes is a growing public health problem that presents high cost for its prevention and 
management by society. Approximately 9% (11% of men and 15% of women) adults aged ≥ 




physical activity contribute to insulin resistance, which in turn leads to high blood 
sugar/diabetes (WHO, 2009). Diabetes is causing 6% of the global deaths, with 83% 
occurring in low and middle-income country (WHO, 2014a). Furthermore, diabetes is 
attributed to causing more than 22% and 16% deaths due to coronary heart diseases and 
stroke worldwide, respectively (WHO, 2009).  
Prevalence of diabetes varies from one region to another and this depends on availability and 
country capacity to utilize available few resources in prevention and management of diabetic 
cases (Bi et al., 2015). According to the International Diabetes Federation (2017) estimates, 
more than 1.7 million people living in the Sub-Saharan region are diabetic and Tanzania has 
been mentioned as among of the country with the highest prevalence of diabetes. Results 
from the current national survey (2012) showed that more than 9% (8% of men and 10% of 
women) of the adult population aged ≥ 25 years were diabetic (Mayige and Kagaruki, 2013). 
A large number (5.7%) of diabetic patients in Tanzania lives in urban areas, while few (2%) 
patients live in rural areas, and men are more affected (3.8%) compared to their counterparts 
(2.9%) (Aspray et al., 2000). Stanifer et al. (2016) documented a prevalence of 21.7% and 
5.7% for diabetes and glucose impairment, respectively, among the study population in a 
study conducted from 2014 to 2015 in Kilimanjaro Region, Tanzania. Diabetes complications 
are increasing all over the world, and in Sub-Saharan countries, including Tanzania where the 
disease is becoming a pressing public health concern (Hall et al., 2011). The proportions of 
diabetic complications in Sub-Saharan region is ranging from 7 to 63% for retinopathy, 27 to 
66% for neuropathy, and 10 to 83% for micro-albuminuria (Hall et al., 2011). Similarly, 
Stanifer et al. (2016) documented a large number of patients with diabetic complications, 
retinopathy (12%), ophthalmic (47%) and neurological disorders (29%) in Tanzania. These 
complications indicate poor management of diabetes among patients, which need to be 
addressed. However, lack of diabetic guidelines, screening tools, poor reporting system, 
inadequate drug therapy and lack of training to health care providers and beneficiaries are 
among the factors that contribute to the higher prevalence of diabetes, together with its 
complications (Peck, 2013; Chiwanga et al., 2016; Mwangome et al., 2017). Early detection 
of diabetic cases and management help to minimize late-stage complications. Furthermore, 
weight loss and regular physical activity also help to reduce diabetes risk (WHO, 2014a). 
There is also a need for the continuous provision of healthcare education to diabetes patients 




(v) Alanine aminotransferase  
Alanine Aminotransferase (ALT) is a liver enzyme that catalyzes the transfer of amino 
groups to generate products in gluconeogenesis and amino acid metabolism (Shen et al., 
2015). Elevated levels of ALT have been recognized as a marker for liver injury and an 
overall health indicator (Shen et al., 2015). Elevated serum ALT is mainly attributed to 
insulin resistance, hypercholesterolemia, hypertriglyceridemia, central obesity (Ioannou et 
al., 2006), and non-alcoholic fatty liver disease (NAFLD), beside viral hepatitis and 
excessive drinking (Shen et al., 2015). Both NAFLD and elevated ALT can serve as 
independent predictors of CHD (Schindhelm et al., 2007).  
The link between elevated levels of ALT and CHD is not much clear from most of the studies 
conducted in different countries. Alanine aminotransferase levels have been used to predict 
servility of CHD among patients in China, whereby higher levels of ALT (> 42.31±8.34 
IU/L) were observed among patients with CHD in control group (18.25±6.38 IU/L) (Shen et 
al., 2015). Additionally, Ioannou et al. (2006) reported increased threshold for CHD in men 
with higher levels of ALT (> 43 IU/L) than in women (> 30 IU/L) and concluded that 
patients with higher levels of ALT have increased the risk for calculated CHD risks. In a 
Framingham Offspring Heart Study participants, both normal and higher levels of ALT were 
associated with the long-term development of multiple metabolic disorders, and in 
conclusion, ALT was identified as a potential biomarker for the risk of developing metabolic 
diseases (Goessling et al., 2008). Higher levels of ALT were also strongly associated with 
central adiposity, hyperinsulinemia, and hyperleptinemia in the third National Health and 
Nutrition Examination Survey (NHANES III) (Ruhl and Everharty, 2003).  
(vi) C - reactive protein (CRP) 
C- reactive protein is an acute phase protein produced by the liver in response to body 
inflammation. Higher levels of CRP in the blood is highly related to different factors, such as 
smoking, high blood pressure, and cholesterol, which stimulate inflammatory reactions in the 
body (Shrivastava, 2015). It plays a key role in many aspects of atherosclerosis process by 
influencing lipid uptake by macrophage, releasing of pro-inflammatory cytokines, inducing 
the expression of tissue factors in monocytes, promoting endothelial dysfunction and 
inhibiting nitric oxide production (Mehta et al., 2007). Furthermore, CRP is well a well-
known predictor for the development of CVDs, including coronary heart diseases, myocardial 




et al. (2002) documented higher levels of CRP of 6.49+/-2.28 mg/L among a group of 
patients with acute myocardial infarction compared to lower CRP level of 4.35+/-2.6 mg/L 
among patients with stable coronary artery diseases and their association was strongly 
significant. In another study, findings showed that patients with higher CRP levels greater 
than 3 mg/L were at higher risk of dying from CHD than those patients with less than 3 mg/L 
of CRP levels (Soinio, 2006). However, the role of CPR as an independent predictor of CVD 
development, especially CHD, was not recognized in other studies (Danesh et al., 2005). 
Wensley et al. (2011) documented that the concentration of CRP alone is unlikely to be a 
modest causal factor for CHD. There is, therefore, need for conducting mechanistic studies 
that will come up with a clear understanding of the relationship between CRP and 
development of CVDs. 
(vii) Serum sodium and potassium levels 
Maintenance of body electrolytes is of great importance in the management of patients with 
CVDs and prevention of future health complications from these diseases (Kughapriya and 
Ponnudhali, 2016). Consumption of dietary sodium and potassium is of public health interests 
due to homeostasis role played in the body. Serum sodium and potassium represent the 
internal environment for the body, and play  important role in the regulation of blood pressure 
(Xi et al., 2015b). However, dietary sodium and potassium may not necessarily reflect their 
level in extracellular fluid (Siani et al., 1987). An increased potassium dietary intake is of 
great interest primarily due to its association in lowering blood pressure and CVD risks 
(WHO, 2012). Potassium levels counteract the negative effects of sodium intakes on blood 
pressure (Mirmiran et al., 2018). Other studies suggest that potassium should not always be 
evaluated as beneficial in terms of lowering blood pressure, as it has been related with 
increased risk for hypertension in Chinese population and other populations (Xi et al., 
2015a). Excessive consumption of dietary sodium is associated with increased risk factors for 
CVD, most prominently with raised blood pressure, renal function, left ventricular 
hypertrophy, and increased arterial stiffness (Xi et al., 2015a). Diet rich in sodium and lower 
potassium has been identified to contributes to the higher prevalence of CVD risk factors in 
another study conducted in Tehran-Iran community (Mirmiran et al., 2018). Despite the 
evidence provided from other previous studies on the relationship between inadequate intake 
of potassium or excess sodium and increased blood pressure still, there is no clear 




hypertension and CVD events (Umesawa et al., 2008). These electrolytes are very commonly 
associated with cardiovascular emergencies, so regular check up on the serum electrolyte 
levels among patients with coronary heart disease help to improve prognosis among these 




















 MATERIALS AND METHODS 
3.1 Materials 
 Neogloves, Syringe with Needle, Microvatte tubes, Eppendorf tube, Vortex mixer, 
stadiometer, Weighing scale, Automatic digital sphygmomanometer (PB machine), 
Centrifuge machine (3000 rpm), Cobas integra 400 analyzer plus, Maglumi 800 analyzer, 
pipette, and blood samples. Detailed information on reagents, equipment and manufactures is 
attached in Appendices 1 and 2.  
3.2 Methods  
3.2.1 Study settings 
This study was conducted at Kilimanjaro Christian Medical Centre (KCMC)-referral hospital, 
located in Kilimanjaro region-Tanzania. Kilimanjaro Christian Medical Centre is a referral 
hospital which serves over 15 million people from the northern, eastern and central zone of 
Tanzania. The hospital has the capacity to serve 500-800 inpatients per day. 
3.2.2 Study design and sampling method 
This was a cross-sectional hospital-based study to determine the prevalence of modifiable and 
intermediate risk factors and their association with CVDs. The study involved outpatients 
with hypertension and coronary heart diseases attending the cardiac clinic at KCMC-referral 
hospital. The study was conducted from April to July, 2018. The purpose sampling method 
was employed to select study participants. 
3.2.3 Sample size 
The sample size was calculated by using the Kish and Lisle formula for cross-sectional 
studies adapted from Israel (1992). 
        
         
  
 
Where: n = minimum required sample size, 
 p = proportion of patients with cardiovascular disease (9%) (WHO, 2010),  




Z = Standard normal distribution at 5% level of significance (1.96).  
   
                   
     
  
      Participants.  
3.2.4 Inclusion and exclusion criteria  
Inclusion criteria: Adults aged ≥ 35 years diagnosed with CHD and HTN who attended the 
Cardiac clinic at KCMC hospital from April to July, 2018. The study participants voluntarily 
consented to participate in the study.   
Exclusion criteria were: Children (including those with congenital heart diseases) and 
pregnant women.  
3.2.5 Data collection tools 
(i) Questionnaire  
A structured questionnaire with closed questions was adopted from the WHO STEPwise 
translated to Swahili language (national language) (Appendix 3). The questionnaire was then 
administered to all participants. The following information was collected: socio-demographic 
information, lifestyle risk factors and family history of hypertension and coronary heart 
diseases. Education level was categorized as primary level, secondary level, higher education 
learning and uneducated. Marital status (married or unmarried), occupation (formal 
employment, self-employed and unemployed). Assessed lifestyle risk factors included: 
current /history of smoking for the past 5 years (classified as Yes or No), present/previous 
history of alcohol intake (Yes or No), physical activity for at least 2 days per week minimum 
for 30 minutes (Yes or No), and family history of either hypertension or coronary heart 
diseases (defined as at least of the close relative (father, mother, sister or brother).  
(ii) Anthropometric measurements  
Weight in kilogram was taken in light clothing by using calibrated weighing scale machine 
(Seca, Germany), with 150 kg capacity of accuracy of 0.5 kg. The patients were requested to 
remain with minimal clothes, removed shoes and excess weight in the pockets before 




(Leicester stadiometer, Germany) of 0.1 cm accuracy, with the subject standing against the 
vertical wall, heels together, shoulders and head touching the wall surface and after removal 
of shoes. Body mass index (BMI) was then calculated by the following formula (BMI = 
(weight (kg)/(Height (m
2
). BMI was categorized as underweight (< 18.5), normal (18.5-24.9), 
overweight (25-29.9) and obese (≥ 30) (WHO, 2014a). 
(iii) Blood pressure measurements 
Blood pressure measurement was conducted by the trained clinical officer upon arrival of the 
patients and after resting for 10-15 minutes. Automatic digital Sphygmomanometer with 
automatic inflation (Life Brand™ BM60) was used to measure blood pressure while the 
patient was seated and relaxed with the left hand at the level of the heart. Three systolic and 
diastolic blood pressure readings were taken on the left upper arm while the patient was 
seated and relaxed. Average systolic and diastolic blood pressure was used in the analysis. 
Systolic and diastolic blood pressure measurements were used to classify hypertension in 
accordance with the Seventh Joint National Committee (SJNC, 2004) (see table 1). 
Hypertension was confirmed by practicing physicians working at the Out-Patient Department 
(OPD), using the below table of classification. 
Table 1: Classification of blood pressure for adults 
 Systolic BP (mmHg) Diastolic BP (mmHg) 
Normal  < 120 < 80 
Pre-hypertension 120–139 80–89 
Hypertension stage –I 140–159 90–99 
Hypertension stage-II ≥ 160 ≥ 100 
(Seventh Joint National Committee, 2004). 
 Blood sample collection and preparation  
Blood samples for plasma glucose, serum ALT, CRP, HDL-C, LDL-C, Na and K 
concentration measurements were obtained by a trained clinician. Ten (10) ml of venous 
blood samples were drawn from the arm of each patient and transferred to 
ethylenediaminetetraacetic acid (EDTA) tube. Blood samples were then taken to a clinical 
research laboratory at KCMC hospital for further analysis procedures. Blood samples were 
centrifuged at the 3000 rpm machine (German) for 5 minutes at 4 
◦
C. Clarified serum and 
plasma samples were then pipetted and poured into Eppendorf storage tubes (5 mls), followed 






(iv) Laboratory analysis of biomarkers  
Before analysis, plasma and serum blood samples were mixed thoroughly by using vortex 
mixer. Form each sample 10 μL were pipetted and poured into Microvatte tubes. Plasma 
blood glucose, HLD-C, LDL-C, ALT, Na, and K samples were loaded into Cobas Integra 400 
plus analyzer (Roche Diagnostics, Germany). Serum blood for measuring CRP concentration 
was loaded into fully-auto chemiluminescence immunoassay (CLIA) analyzer (MAGLUMI 
800) Shenzhen New Industries Biomedical Engineering Co., Ltd (Snibe Diagnostic), China. 
According to laboratory protocols, values (concentrations) of studied biochemistry markers 
were categorized as indicated in Table 2. 
Table 2: Classification of biochemical markers 
Biomarkers  Descriptor 
Plasma glucose   
3.5-6.5 Normal 
> 6.5 Hyperglycemia/diabetes  
HDL-C (mmol/L)  
> 1.45- > 1.68 Normal  
0.90-1.68  Moderate risk 
0.90- < 1.15 High risk 
LDL-C (mmol/L)  
< 2.59-3.34  Normal  
> 3.34- ≥ 4.92 High risk  
ALT (IU/L)  
< 31  Normal- male 
< 19  Normal- female 
> 31  High risk - male 
> 19  High risk-female 
Sodium (mmol/L)  
136-145 Normal 
> 145  High  
Potassium (mmol/L)  
3.50 - 5.10  Normal  
> 5.10  High  
CRP (mmol/L)  
< 1  Normal  
1-3  Moderate risk 
> 3  High risk 
NOTE: HDL-C, high-density lipoprotein cholesterol, LDL-C, Low-density lipoprotein cholesterol, ALT, alanine 
aminotransferase, CRP, C-reactive protein 
3.3 Statistical analysis  
Data were entered in into Microsoft Excel 2013, and then sorted, coded, and cleaned. The 
analysis was done using SPSS version 20.0 (IBM). Descriptive statistics were used to analyze 
the frequency and percentages of socio-demographics, lifestyle characteristics, and 
biomarkers for HTN and CHD. Pearson’s Chi-Square (χ
2
) test was used to determine the 




analysis were: gender, age, education level, occupation, marital status, BMI, blood pressure, 
physical activity, smoking history, alcohol consumption, plasma blood sugar, ALT, HDL-C, 
LDL-C, CRP, Na and K levels. Independent variables significantly associated with HTN and 
CHD in Pearson’s Chi-square test were subjected to multinomial logistic regression analysis 
model to reveal potential risk for HTN and CHD. Upon building the final model only 
variables which were statistically associated with HTN and CHD were included. Statistical 
significance was tested at 95% confidence interval (alpha ≤ 0.05). 
3.4 Ethical clearance and informed consent 
This study was approved by ethics committee from Tanzania National Institute for Medical 
Research (NIMR) (NIMR/HQ/R.8a/Vol.IX/2737) and from Kilimanjaro Christian Medical 
Centre-referral hospital. Participants were well informed about the aim of the study. Written 






 RESULTS AND DISCUSSION 
4.1 Results  
4.1.1 General characteristics of the population  
A total of 100 patients with HTN and CHDs who attended the cardiac clinic at Kilimanjaro 
Christian Medical Centre (KCMC) referral hospital between April to July, 2018 were 
recruited and consented to participate in this study. Socio-demographic characteristics of the 
patients were as summarized in Table 3. Out of 100 patients, 31% were males and 69 were 
females. Majority of the patients were educated, with 45% primary education, 32% secondary 
education, and 14% higher education (college and university), while only 9% had no formal 
education. More than three-quarter (81%) of the patients were within the age category of 45 
years and above, while only 19% were below 45 years. Seventy-three percent of the patients 
were married and 27% had no partner. Most of the patients (72%) were self-employed, 15% 
had formal employment, and 13% had no formal employment. Furthermore, results showed 
that 53% of the patients had a family history of hypertension and coronary heart diseases, and 






Table 3: Socio-demographic characteristics of participants 
Variables  Frequency (N=100) Percentage (100%) 
Gender    
Men 31 31 
Women 69 69 
Age    
<45 19 19 
>45 81 81 
Education level   
Higher education learning 14  
Primary level 45 14 
Secondary level 32 45 
No formal education 9 32 
Marital status   
Married 73 73 
No partner 27 27 
Occupation   
Formal-employment 15 15 
Self-employed 72 72 
Unemployed 13 13 
Family history   
Yes  53 53 
No  47 47 
Types of other chronic diseases   
Chronic kidney  diseases 11 25 
Arthritis  7 15.9 
Diabetes  15 34.1 
Stomach ulcers 9 20.5 
Valve failure 2 4.5 
Herbal medicine   
Yes  36 36 
No  64 64 
 
4.1.2 Percentage of the patients diagnosed with hypertension and coronary heart 
diseases  
Results presented in Fig. 1 shows types of CVDs which were clinically diagnosed from the 
study patients. Sixty-five percent of the patients were hypertensive, and 35% suffering from 





Figure 1: Percent of patients diagnosed with hypertension and coronary heart disease  
4.1.3 Proportion of lifestyle risk factors among study patients 
(i) Lifestyle risk factors 
The proportion of lifestyle risk factors for hypertension and coronary heart diseases assessed 
from each patient participated in this study is summarized in Fig. 2. Nearly two-third (61%) 
of the patients who participated in this study did not engage in physical activity for at least 30 
minutes per two days of a week, with only 39% of the patients engaged in physical activity. 
Among the study participants, 67% patients had a current history of alcohol intake while 33% 
patients never took alcohol. More than three-quarter (89%) of the patients were consuming 
salty food and very few (11%) were restricted to use salt foods. Furthermore, the majority 
(82%) of the patients were non-smokers while few (17%) reported a current history of 
smoking.  
 





































(ii) Distribution of lifestyle risk factors for hypertension and coronary heart diseases 
by gender 
Figure 2 shows the gender distribution of the lifestyle risk factors for hypertension and 
coronary heart diseases. With the exception of the history of smoking, female patients were 
more likely exposed to alcohol intake and physical inactivity than male patients.  
 
Figure 3: Gender distribution of lifestyle risk factors for hypertension and coronary heart 
diseases.  
 
(v) Dietary habit of the patients 
Dietary habits of the patients are presented in Fig. 4. The majority of the patients were 
consuming ≥ 3 servings/week of cereals (60%) and legume (36%) based foods. There was a 
low intake of fruits and vegetables among study patients. A large number of patients were 
consuming less than three serving of fruits and vegetable per week, with only 34% of patients 





























Figure 4: Patterns of dietary habits among study patients 
4.1.4 Assessment of the blood pressure and nutritional status of the patients 
(i) Assessment of blood pressure among patients  
As shown in Table 2, more than half (59%) of patients were classified as hypertensive, 21% 
being stage I and 38% being stage II. Twenty-six percent (26%) of patients were pre-
hypertensive, and 15% had normal blood pressure 
Table 4: Distribution of blood pressure among study patients 
Variable  Frequency Percentage (%) 
Blood pressure    
Normal (< 120/80) 15 15 
Pre-hypertension (120-139/80-89) 26 26 
Hypertension-stage I (140-159/90-99) 21 21 








































(ii) Assessment of the nutritional status of  patients 
Nutritional status of the patient was assessed through body mass index and the results are 
presented in Fig. 5. Only 25% of the patients had normal body weight, 36% were overweight 
and 39% were obese.  
 
Figure 5: Prevalence of overweight and obesity among patients 
4.1.5 Prevalence of biomarkers for hypertension and coronary heart diseases among 
study patients 
High concentration of biomarkers for hypertension and coronary heart diseases were also 
recorded among study patients participated in this study. The most prevalent biomarkers 
found among patients were low-density lipoproteins (65%), C-reactive protein (60%), and 
alanine aminotransferase (40%) (Table 5). Furthermore, a higher concentration of serum 












Table 5: Determination of biomarkers for hypertension and coronary heart diseases among 
patients  
Biomarkers Frequency Percentage (%) 
Plasma glucose (mmol/L)   
Normal (3.5-6.5) 67 67 
Hyperglycemia/diabetes ( > 6.5) 33 33 
   
HDL-C (mmol/L)   
Normal (>1.45 to > 1.68) 21 21 
Moderate risk(0.90 to 1.68) 50 50 
High risk (0.90 to < 1.15) 29 29 
   
LDL-C (mmol/L)   
Normal (< 2.59 to 3.34) 35 35 
High risk (> 3.34 to ≥ 4.92) 65 65 
   
ALT  (IU/L)   
Normal- male ( < 31) 25 25 
Normal- female (< 19) 32 32 
High risk – male ( > 31) 6 6 
High risk-female ( > 19) 37 37 
   
Sodium (mmol/L)   
Normal (136-145) 59 59 
High ( > 145) 41 41 
   
Potassium (mmol/L)   
Normal (3.50 - 5.10) 60 60 
High ( > 5.10) 40 40 
   
CRP (mmol/L)   
Normal ( < 1 )  22 22 
Moderate risk (1-3) 18 18 
High risk ( > 3) 60 60 
NOTE: ALT, alanine aminotransferase, CRP, C-reactive protein, LDL-C, low density lipoprotein cholesterol, 
HDL-C, high density lipoprotein cholesterol.  
 
4.1.6 The association between socio-demographic characteristics, lifestyle, and 
biomarker/intermediate risk factors with hypertension and coronary heart 
diseases 
Socio-demographic characteristics, lifestyle and intermediate risk factors studied in this study 
were associated with hypertension and coronary heart diseases and the findings were 
presented in Table 6. The association between gender, hypertension, and CHD were 
statistically significant at p ≤ 0.05. Likewise, age showed a statistical association with 




between education level, occupation with hypertension and coronary heart diseases among 
study patients. Furthermore, with the exception of smoking history, which showed significant 
association with hypertension and CHD (p ≤ 0.05), physical activity, alcohol intake, blood 
pressure, and body mass index were not associated with hypertension and coronary heart 
diseases (Table 6). 
 Regarding biomarkers for hypertension and coronary heart diseases, plasma blood glucose, 
serum alanine aminotransferase, serum low-density lipoprotein cholesterol (LDL-C), serum 
high-density lipoprotein cholesterol (HDL-C), serum C-reactive protein (CRP), and serum 
potassium level were all positively associated with hypertension and coronary heart diseases 
at p-value ≤ 0.05 (see Table 6). There was no statistical association between sodium levels, 
hypertension and coronary heart diseases (p > 0.05) (Table 6). 
 
Table 6: Association between socio-demographic, lifestyle risk factors, and biomarkers for 
hypertension and coronary heart diseases  
Variables                      Diseases type  X
2
-test 
 HTN (N = 65%) CHD (N = 23%) p- value 
Socio-demographics    
Gender     
Males  22 9  
0.007* Females  43 26 
Age     
<45 4 15  
>45 61 20 0.000* 
Education level    




SEC 20 12 
PR 28 17 
NE 8 1 
Occupation    
Formal employment 9 6  
 
0.614 
Self-employed 45 27 
unemployed 11 2 
Lifestyle risk factors  
Physical activity   
Yes   28 11  
0.350 No 37 24 
History Smoking  
Yes  10 7  
0.040* No  55 28 
Alcohol consumption  




























Variables                        Diseases type          X
2
-test  
 HTN (N = 65%) CHD (N = 23%) p- value 
Blood pressure     
Normal  4 11  
Pre-hypertension 18 8  
Hypertension stage-I 16 5 0.086 
Hypertension stage -II 29 9  
Bio markers    
Plasma glucose    
Normal  38 31  
0.004* Hyperglycemia/diabetes 27 4 
ALT    
Normal 43 14  









0.016* High risk 41 24 
HDL-C    






Normal -females 6 8 
Moderate-males 9 8 
Moderate-females 22 14 
High risk-males 6 3 
High risk-females 14 6 
CRP    
Normal  18 4  
 
0.033* 
Moderate risk 12 6 
High risk 35 25 
Na     
Normal  38 21  
0.068 High risk 27 14 
K    
Normal  39 21  
0.001* High risk 26 14 
* 
Values were statistically significant (p ≤ 0.05), HTN, Hypertension, CHD, Coronary Heart Diseases, ALT, 
alanine aminotransferase, CRP, C-reactive protein, HDL-C, High-density lipoprotein cholesterol, LDL-C, Low-
density lipoprotein cholesterol, Na, Sodium, K, Potassium  
 
4.1.7 Determination of contributors of risk for HTN among patients 
Results from Pearson Chi-Square (  ) showed that gender, age, history of smoking, plasma 
blood glucose, alanine aminotransferase low-density lipoprotein, C-reactive protein, and 
potassium levels were significantly associated with HTN. However, when subjected to 
multinomial logistic regression only age, alanine aminotransferase and glucose were 
independently associated with HTN risk (Table 7).  
Moreover, the association between age and HTN risk was significant. Those patients aged < 
45 years (OR = 0.17, CI = 0.047-0.612) were at more risk for hypertension than those aged > 
45 years. Moreover, those with normal ALT had a lower risk for hypertension (OR = 3.24, CI 




association between HTN risk and blood sugar, and patients with normal blood sugar (OR = 
0.22, CI = 0.62-0.76) had reduced risk for hypertension than diabetic patients.  
Table 7: Results from multinomial logistic models to determine significant predictors of 
hypertension 







 Exp (B) 
95% CI of OR 
Age       
<45 -1.78 0.66 0.007 0.17 0.047-0.612 
>45 Reference      
ALT      
No risk -1.18 0.49 0.018 3.24 1.22-8.57 
Risk  Reference      
Glucose       
Normal  -1.53 0.64 0.016 0.22 0.62-0.76 
Hyperglycemia/diabetes Reference     
NOTE: ALT, Alanine aminotransferase 
4.1.8 Determination of contributors for CHD risk among patients 
As shown in Table 8, the association between CHD risk and age was statistically significant 
(P = 0.002). Patients aged < 45 years were almost four times at high risk for suffering from 
CHD (OR = 9.82, CI = 2.37-40.62) compared to those aged > 45 years. The risk for CHD 
was higher among patients with high ALT levels compared to those with normal ALT levels 
(OR = 0.34, CI = 0.12-0.93). Compared to patients with normal blood sugar (OR = 4.77, CI = 
1.31-17.42), those patients with high ALT levels were more likely to suffer from CHD. 
Further results showed that patients with normal CRP (OR = 0.25, CI = 0.08-0.79) had 
reduced risk for CHD compared to those with higher CRP levels.  
Table 8: Results from multinomial logistic models to determine significant predictors of 
coronary heart diseases 
Variable Parameter 
Estimated (B)  
Standard 
error 
P-value OR / Exp 
(B) 
95% CI of 
OR 
Age       
<45 2.28 0.72 0.002 9.82 2.37-40.62 
>45 Reference      
ALT      
No risk -1.09 0.52 0.035 0.34 0.12-0.93 
Risk  Reference      
Glucose       
Normal  -1.56 0.66 0.018 4.77 1.31-17.42 
Hyperglycemia/diabetes Reference     
CRP      
Normal -1.38 0.58 0.018 0.25 0.08-0.79 
High level Reference     




4.2 Discussion  
The current study provides an overview of prevalence of CVDs risk factors among patients 
diagnosed with CHD and HTN attending the cardiac clinic at a referral hospital in Tanzania. 
Findings from the current study showed higher prevalence of HTN and CHD, with higher 
proportion of patients being exposed to CVDs risk factors despite the fact that they were 
under clinical management. To date, there were only two studies (Kitange et al., 1993; Swai 
et al., 1993) conducted in Tanzania as related to CHD and their associated risk factors. These 
studies have reported a lower prevalence of CHD and their associated risk, contrary to the 
current findings which showed a higher prevalence of CHD and their associated risk factors. 
This might be due to the fact that the present study was conducted at a hospital setting and all 
patients involved had known medical conditions (HTN and CHD). Furthermore, results from 
this study reflect the current growing trend of CVDs, which is characterized by changes in 
lifestyle and epidemiological transition within the country (Blomstedt et al., 2012). 
4.2.1 Lifestyle risk factors  
Results from this study present a higher prevalence of the lifestyle risk factors among study 
patients. More than two-third of the patients who participated in the study were physically 
inactive, with female patients being more inactive than male patients. Low level of physical 
activity among patients has been related to aging, cardiovascular symptoms and other chronic 
diseases such as arthritis that reduces walking ability. The general health condition of the 
patients, shortage of breath, fatigue, and weakness have been reported as factors that lower 
levels of physical activity among patients with CHD (Press et al., 2003; Stewart et al., 2013). 
Percentage of physically active patients in this study were higher compared to 17% reported 
from the National Health and Nutrition Examination Survey 2007-2010 (Tang et al., 2013). 
As reported by Darden et al. (2014) patients with established risk of CHD have significant 
benefits from regular physical activity, and patients should be well encouraged to engage in 
any physical activity for the improvement of general health condition.  
All patients in this study were using drugs for treatment of HTN and CHD, and more than 
two-third of them had a current history of alcohol intake. Patients with history of alcohol 
intake were more affected with HTN and CHD than non-alcohol users. This is may be due to 
contribution of alcohol in the formation of atherosclerosis and thrombotic lesions (Mukamal 
and Rimm, 2001) that worsen the diseases and overall health condition of the patients. The 




alcohol reported from the National Health and Nutrition Examination Survey (Tang et al., 
2013), 17.2% by Mbatia et al. (2009) and 20% in the rural and 22% in urban setting of 
Tanzania Francis et al. (2015). This finding suggests lower level of knowledge on the effects 
of alcohol intake on the overall health status and reduction of drug efficacy and efficiency. 
This may also reduce the rate of recovery from the disease and may result in more health 
complications (Conen, 2015).  
Furthermore, only 17% of the patients were smokers, and all were males similar with that 
reported in the EUROASPIRE III survey carried out in 2006-2007 in 76 centres from selected 
geographical areas in 22 countries in Europe (Kotseva et al., 2009). Compared to previous 
findings in the country, the proportion of smokers in this study were lower than that reported 
by Bovet et al. (2002) (27% in men and 5% in women), Jogoe et al. (2002) 26% and 2.9% in 
men and women, respectively. This study presumes that the lower prevalence of smoking 
among patients was associated with few numbers of patients involved in the study.  
4.2.2 Dietary habits of study patients 
The main food source consumed by the study participants were cereals and tubers based 
foods along with legumes. Consumption of legumes has been recognized to reduce the effect 
of heart diseases especially CHD, due to the high content of protein and water-soluble fiber 
which counteract the effect of serum cholesterol (Bazzano et al., 2001). Consumption of 
cereal-based food is of great importance as it contains dietary fibers and other potentially 
cardio-protective components, which reduce total cholesterol and improve glycemic control 
in diabetic patients (Truswell, 2002; Mann, 2007). Patients should be encouraged to eat 
unprocessed cereals-based foods since processed cereals have reduced nutrient contents and 
bio-protective substances. Consumption of animal foods and their products were moderate, 
however, few patients reported intake of more than 3 servings of fruits and vegetables per 
week and this might contribute to the higher levels of blood cholesterol observed to the 
patients. Majority of the patients were consuming less than 3 servings of fruits and vegetables 
per week and this has been related with low knowledge on the importance of consuming 
fruits and vegetables and the protective effects of the nutrients on the prevention and 
reduction of heart diseases.  
4.2.3 Blood pressure and nutritional status of patients 
Despite that all patients were receiving drugs for treatment and control of HTN and CHD, 




had uncontrolled blood pressure (systolic blood pressure ≥ 140 mmHg and diastolic blood 
pressure ≥ 90 mmHg, contrary to 50% prevalence of uncontrolled blood pressure reported 
among patients suffering from CHD in EUROASPIRE II Heart Survey Programme (Kotseva 
et al., 2001). These findings were inconsistent with that reported in hospital hypertension 
unit-Spain by Banegas et al. (2004) which found only 42% of the patients had to achieve the 
targeted goal of lowering blood pressure. The current prevalence of hypertension was almost 
similar with 57% by (Njelekela et al., 2009) and lower compared to 37% prevalence of HTN 
shown by Zack et al. (2017) in the studies conducted in Dar es Salaam. Higher levels of 
blood pressure among patients might be related with higher consumption of dietary salt (89% 
of patients) and use of hypertensive drugs that have been reported to contribute to the 
metabolic effects of thiazide to CHD risk (Olafiranye et al., 2011). Dietary salt does not only 
increase blood pressure but also causes endothelial dysfunction, albuminuria, and 
development of kidney disease (Kristal et al., 2014). Control of blood pressure is more 
important than the choice of anti-hypertensive drugs in the prevention of CHD and other 
CVD events.  
On the other hand, more than one-third of the participants were overweight (36%) and obese 
(39%), respectively. This has been related to the lower level of physical activity and poor 
eating habits characterized by low consumption of fruits and vegetables among study 
participants. The prevalence of overweight and obesity found in this study is likely to worsen 
the health status of the patients as it increases other CVD risks (Kotseva et al., 2001). The 
current prevalence of overweight and obesity was lower compared to that reported in Egypt 
(overweight 44% and obesity 36%) and Ghana (overweight 30%, obesity 32%) (Amugsi et 
al., 2017). Health interventions focusing on a healthy diet, physical exercise, and weight 
management are urgently needed to rescue patients from other health complications.  
4.2.4 Biomarkers for hypertension and coronary heart diseases 
 Results from this study revealed substantial higher levels of studied biomarkers for both 
HTN and CHD among study participants. These biochemical markers are also regarded as 
intermediate risk factors for CVDs as revealed in the literature review.  
The proportion of abnormal LDL-C and HDL-C was significantly higher in the study 
population, particularly among women, and this has been linked to lifestyle changes. 
Findings from this study correspond with other study findings that showed higher proportions 




Higher consumption of animal foods (meat, milk, and eggs), low intake of fruits and 
vegetables, low physical activity are among the factors that can contribute to the higher 
serum cholesterol among study participants. 
In the current study, one-third of the patients had uncontrolled blood sugar, which was lower 
compared to 87% of the patients with higher (> 6 mmol/L) plasma glucose reported in the 
EUROASPIRE II Heart Survey (Kotseva et al., 2001). The overall prevalence of diabetes in 
the current study was higher compared to 21.7% reported in Kilimanjaro region by Stanifer et 
al. (2016) and 5% and 2% found in urban and rural Tanzania, respectively (Aspray et al. 
2000). For diabetic patients, blood pressure should be treated to > 80 mmHg in order to 
reduce other health complications (American Diabetes Association, 2003).  
Majority of the patients who participated in the study had elevated levels of serum electrolyte 
(sodium > 145 mmol/L and potassium > 5.10 mmol/L) and this was linked with higher salt 
intake observed among patients. Similar finding was previously reported from 5-years 
follow-up study, which found higher levels of K (≥ 4.80 mEq/L) in the group of hypertensive 
patients and lowest level of serum K (4.40-4.59 mEq/L) among the control group (Xi et al., 
2015). High consumption of salty foods and antihypertensive drugs can block the renin-
angiotensin-aldosterone system, thereby impairing kidneys ability to excrete potassium. 
Dietary diversification has been linked with serum K and Na levels. For example, 
unprocessed foods including beans and peas, nuts, vegetables such as spinach, cabbage and 
parsley and fruits, such as bananas, papayas, and dates are good sources of K and Na.  
Furthermore, higher levels of ALT were recorded among patients, with females (37%) being 
with higher ALT levels of > 19 IU/L compared to 6% with > 31 IU/L of males. This might be 
related to alcohol consumption, insulin resistance, obesity and other chronic diseases such as 
renal diseases that influence the synthesis of ALT in the liver (Ioannou et al., 2006). The 
present findings were similar to that documented in the cross-sectional analysis conducted in 
the United States (Ioannou et al., 2006) of which 267 CHD patients had > 42 IU/L ALT 
levels. The findings herein are contrary to 12% of the patients found with higher ALT 
concentration in a study conducted in a primary care setting in central Virginia from 2010 to 
2011 (Siddiqui et al., 2014).  
Further findings showed that, more than three-quarters of the study patients (77%) were 




levels. Similar findings were reported in a Framingham Heart Study by Wilson et al. (2005) 
and by Arima et al. (2008) on the Hisayama study. Higher levels of CRP observed in this 
study have been associated with a higher prevalence of smoking, obesity, and aging and, the 
presence of other chronic diseases.  
 4.2.5 The association between socio-demographics, lifestyle risk factors, nutritional 
status, and biomarkers with hypertension and coronary heart diseases   
 Factors that were found to have an association with HTN and CHD in this study were: Age, 
Alanine aminotransferase, diabetes, and C-reactive protein. Patients aged < 45 years had 
reduced risk of being hypertensive than patients aged > 45 years. However, in this study, the 
onset of coronary heart diseases seem to develop early among patients aged < 45 years than 
those aged > 45 years. This might be related with rapid urbanization, sedentary lifestyle, and 
adoption of westernized dietary habits. (Milane et al., 2014; Katalambula et al., 2017).  
The association between ALT, HTN, and CHD observed in this study was similar with that 
reported by Goessling et al. (2008) and Adibi et al. (2007) in their studies. Patients with 
higher concentration of ALT had higher risk of hypertension and CHD than patients with 
normal ALT levels (Goessling et al., 2008). Interventions aimed at reducing elevated ALT 
levels to normal may help to slow down the process of atherosclerosis. Furthermore, 
preventive strategies should be monitored at least partly by using liver function test.  
The association between CRP, HTN, and CRP was observed in the current study, similarly 
with findings from other related studies (Cesare et al., 2008; Kaptoge et al., 2010; Dong et 
al., 2014). Moreover, findings from epidemiological data also show an association between 
higher CRP levels and future CVD morbidity among patients with known CHD (Danesh, 






 CONCLUSION AND RECOMMENDATIONS 
5.1 Conclusion  
This study provides insight into the management of hypertension and coronary heart diseases 
among patients visiting the cardiac clinic at KCMC referral hospital in Kilimanjaro region. 
The study revealed higher prevalence of both lifestyle risk factors and related biomarkers for 
hypertension and coronary heart diseases among patients, despite the fact that the patients 
were under clinical management. This may indicate inadequate management of these risk 
factors among patients visiting the cardiac clinic, including lack of education on life style risk 
factors for CVDs among population. Poor management and monitoring of these risk factors 
can delay treatment outcome and leading to more health complications, like stroke, which 
will increase health cost of treatment and management at individual and population levels. 
Lifestyle modification, of especially healthy food choice and increased physical activity 
provides preventive measures in reduction and prevention of CVDs. Furthermore, evidence 
from this study demonstrated a key role played by inflammatory markers, particularly CRP 
and ALT, in the pathogenesis of cardiovascular diseases, which calls for further mechanistic 
studies involving the two biomarkers. Regular checkup, education and monitoring of both 
lifestyle risk factors and biomarkers for CVDs, should be carried among patients with CHD 
and HTN will help in their management both at hospital levels and population levels. 
5.2 Recommendations 
(i) Study results herein call for sensitization programs, to include more interventions, 
such as health education on lifestyle risk factors in order to raise patients’ awareness 
of lifestyle modification including proper healthy eating. Apart from drug therapy, 
lifestyle advice should be well structured and tailored to all patients with 
cardiovascular diseases based on their individual needs.  
(ii) Regular checkup and monitoring of both lifestyle risk factors and biomarkers for 
CVDs in patients with HTN and CHD will help in improvement of their management 
and establishment of appropriate interventions.  
(iii)  This study recommends for a larger prospective study with larger sample size and 
long-term follow-up, to evaluate management outcomes among patients visiting 




(iv) The study also recommends for placement of nutrition officers/dietitians in Tanzanian 
hospitals by the Government, to provide education on physical activity and dietary 
counseling to the CVD patients, as one of the key strategy in their management.  
5.3 Limitations of the study 
The following were the limitations in this study: 
(i) Lack of enough financial resources, which led to limited chemicals and reagents, 
which limited the number of study participants. 
(ii) However, despite the obvious limitation, this study provides important novel insights 
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Appendix 1: List of chemical and reagents   
Name of the chemical/reagent Manufacturers  
ISE Reference Electrolyte cobas Integra 
(250mL): 
Roche Diagnostics GnbH Sandhofer 
Strasse 116, D-68305 Mannheim, 
Germany. 
ISE Calbrator indirect cobas integra (250mL): 
150 mmol/l of Na
+
, 5 mmol/l of K
+
, 0.3 mmol/l 
of Li
+
, 115 mmol/l of Cl.  
Roche Diagnostics GnbH Sandhofer 
Strasse 116, D-68305 Mannheim, 
Germany. 
MAGLUMI CRP (CLIA): Nano magnetic 
microbeads (2.5 ml), Calibrator low (2.5 ml), 
Calibrator high (2.5 ml), FITC Label (12.5 ml), 
ABEI Label (22.5 ml), Diluent ( 25.0 ml) and 
2.0 ml of Internal Quality Control. 
Shenzhen New Industries Biomedical 
Engineering Co., Ltd. (snibe). 4/F, 
Wearnes Tech Bidg, Science &Industry 
Park, Nanshan, Shenzhen,518057 China 
Alanine aminotransferase COBAS 
INTEGRA/cobas C system: 
 R1: TRIS buffer: 224 mmol/L, pH 7.3 (37oC); 
L-alanine: 1120 mmol/L; albumin (bovine): 
0.25%; LDH (microorganisms): > 45 ukat/L; 
stabilizers; preservative R2: 2-Oxoglutarate: 94 
mmol/L; NADH: > 1.7 mmol/L 
Roche Diagnostics GnbH Sandhofer 
Strasse 116, D-68305 Mannheim, 
Germany. 
COBAS Integra 400 Plus Glucose HK Liquid-
800 tests: R1 MES buffer: 5.0 mmol/L, pH 6.0; 
Mg2+: 24 mmol/L; ATP: > 4.5 mmol/L; NADP: 
> 7.0 mmol/L; preservative 
R2 HEPES Buffer: 200 mmol/L, pH 8.0; Mg2+: 
4 mmol/L; HK (yeast): > 3 00 ukat/L; G-6-PDH 
(E.coli): > 300 ukat/L; preservative. 
Roche Diagnostics GnbH Sandhofer 








Appendix 2: List of equipments  
Name of the equipment  Manufacturer  
Neogloves  Neomedic limited, Great Glove (Thailand) 
Co., Ltd 
Neoject Non-Pyrogenic Auto Disable 
Syringe with Needle 
Neomedic Limited, China 
Microvatte tubes, Eppendorf tube Neomedic Limited, China 
Vortex mixer Germany 
stadiometer Leicester stadiometer 
Weighing scale  Seca Germany 
Automatic digital sphygmomanometer (PB 
machine) 
(Life Brand™ BM60) 
Centrifuge machine (3,000 rpm) Made in Germany 
Cobas integra 400 analyzer plus Roche Diagnostics GnbH Sandhofer Strasse 
116, D-68305 Mannheim, Germany 
Maglumi 800 analyzer  Shenzhen New Industries Biomedical 
Engineering Co., Ltd. (snibe) 4/F, Wearnes 
Tech Bidg, Science and Industry Park, 






Appendix 3: Questionnaire sheet 
Overview of the study  
Am conducting a study in your region with the aim of establishing the association between 
lipids, ALT, CRP and sodium/ potassium levels, nutritional status and food habits among 
cardiovascular diseases patients in Kilimanjaro region-Tanzania. Am requesting you to 
provide with correct information which will be very important towards implementation of 
right diagnosis methods and to design intervention with the implications of reducing and 
preventing cardiovascular diseases in the community. I promise that the information you 
provide will be preserved with highest confidentiality.  
Do you agree to proceed with the interview?   Yes   No 
Kindly am requesting you to fill the gap below with correct information 
 
Questionnaire Part 1: Information on socio-demographics, behavioral and intermediate risk 
factors of the patients  
Questions  Response 
Socio-demographic characteristics  
Patient ID  
Sex   
Age (Year of birth)  
Education level  
Marital status  
Occupation   
Anthropometric measurements  
Body weight (Kg) BMI 
Height (m) 
Blood pressure measurement  
Systolic  1. 
2.  
Diastolic  1. 
2. 




Physical Activity  
In a typical week, how many days do you 
perform vigorous-intensity activities as part 
of your work? 
1. Yes  
2. No  
How much time do you spend doing 
vigorous-intensity activities at work on a 
typical day? 
1. < 30 minutes 
2. 30 minutes  
If yes which kind of physical activity do you 
usually perform? 
 
1. Walking  
2. Gardening 
3. Running  
4. Others, mention 
Alcohol consumption  
Have you ever consumed an alcoholic drink 
such as beer, wine, spirits, fermented cider 
1. Yes  
2. 2. No  
 Have you consumed an alcoholic drink 
within the past 2 months? 
1. Yes  
2. No  
If yes, please mention the type of alcohol  1. 
2. 
3. 
Smoking   
Do you currently smoke any tobacco 
products, such as cigarettes, cigars or pipes? 
 
1. Yes  
2. 2. No  
In the past, did you ever smoke daily? 1. Yes  
2. 2. No  
Dietary factors   
In a typical week, on how many days do you 
eat fruit? 
Number of days  
How many servings of fruit do you eat on 
one of those days?  
Number of servings 
In a typical week, on how many days do you 
eat vegetables? 
Number of days 




on one of those days? 
History of chronic diseases   
Have you ever had any history of heart 
diseases 
1. Yes  
2. 2. No 
If yes, please mention the type of diseases  1. Hypertension 
2. Coronary heart disease 
Do you have any other chronic diseases than 
hypertension and coronary heart diseases 
1. Yes 
2. 2. No  




Do you have any relative who have suffered 
from hypertension and coronary heart disease 
or any other heart disease? 
1. Yes  
2. No  
Relation with this relative? Eg. Father  
Which condition are they suffering from?  
Alternative medicines  
Are you using any herbal medicine for 
treatment of coronary heart disease and 
hypertension/any other diseases? 
1. Yes 
2. No  
If yes, please mention the name(s) of the 
herbal medicine you usually use for 
treatment of coronary heart disease and 
hypertension/any other disease 
 
Where do you found these herbal medicines?  




Questionnaire part II: Dietary practices/Food frequency questionnaire  
Below is a table that contains a list of different types of foods, you are requested  to put a (V) 
mark in the correct column to show how many times you usually eat these foods.  
 








a) MAIN STAPLES      
Banana      
Maize      
Rice       
Cassava      
Yams      
Sweet potatoes      
Mention if there is any other 
staples that is not in a list above  
 
1.      
2.      
3.      
b) LEGUMES      
Cooked cowpeas      
Cooked beans      
Soya beans      
Pigeon peas      
Mention if there is any other 
legumes that is not in a list 
above 
1.      
2.      
3.      
c) FOODS OF ANIMAL ORIGIN AND ITS 
PRODUCTS 
     
Beef       
Goat meat      
Sheep meat      
Pig       
Poultry      
Milk      
Cheese       
Eggs       
Fish      




animal origins  
 
2.      
3.      
d) FRUITS AND VEGETABLES      
Amaranth      
Spinach      
Nightshade      
Avocado      
Ripe Banana       
Mango       
Pineapple      
Watermelon       
Pawpaw       
Oranges      
Mention if there is any other 
fruits and vegetables  
1.      
2.      
3.      
e) BEVERAGES       
Fresh fruits juice      
Artificial juice      
Soda       
Coffee      
Black tea      













Appendix 4: Informed consent  
THE NELSON MANDELA AFRICAN INSTITUTION OF SCIENCE AND 
TECHNOLOGY (NM-AIST) 
 
Office of the Deputy Vice-Chancellor 
Academic, Research & Innovation  
 
Direct Line: +255 027 2970002 
Mobile Phone: +255 0754 436316 






 P. O. Box 447 
                                                          Arusha.                           
TITLE: ASSESSMENT OF BIOCHEMICAL MARKERS AND THEIR 
ASSOCIATION WITH CARDIOVASCULAR DISEASES IN PATIENTS FROM 
KILIMANJARO REGION 
CONSENT FORM: Please read the following to the respondent precisely. 
You are being asked to take part in a research study on “Assessment of Lifestyle Risk 
Factors Among Cardiovascular Disease Patients Attending Kilimanjaro Christian 
Medical Centre in Tanzania”. We are asking you to take part in this study because you fit in 
the set criteria. Please listen carefully and ask any questions you may have before agreeing to 
take part in the study. 
What the study is about: The purpose of this study is to establish an association between 
lipids, ALT, CRP, glucose, and sodium (Na)/ potassium (K) levels, nutritional status and food 




What we will ask you to do: If you agree to participate in this study, we will ask you some 
questions about your daily dietary intake, we will collect 10ml of your blood for analysis of 
blood cholesterol, alanine aminotransferase, C- reactive protein, blood glucose, sodium, and 
potassium levels, weight and height measurements and other questions about your family 
history, results will be given to you. 
The survey will take about 45 minutes to complete. We may contact you again in the future to 
follow up on how you are doing. 
Risks: There is the risk that you may find some of the questions about your dietary habits to 
be sensitive. 
Benefits: Immediately, you will get to know your blood test results and in a longer-term this 
is beneficial in improving diagnostic methods, to plan and design an appropriate intervention 
for prevention and control of cardiovascular diseases especially coronary heart diseases and 
hypertension to the whole community. 
Compensation: There is no compensation for taking part in this study. 
Confidentiality: Your answers will be confidential. The records of this study will be kept 
private. In any sort of report, we make public we will not include any information that will 
make it possible to identify you. Research records will be kept in a locked file; only the 
researchers will have access to the records. 
Taking part is voluntary: Taking part in this study is completely voluntary. You may skip 
any questions that you do not want to answer. If you decide not to take part or to skip some of 
the questions, it will not affect your current or future relationship with the researcher or 
Nelson Mandela African Institute of Science and Technology, the District or Regional 
Council. If you decide to take part, you are free to withdraw at any time. 
If you have questions: The researchers conducting this study: Wilfrida Roman email: 
romanw@nm-aist.ac.tz Phone: 0762689277 





Participant Name: …………Date:…………. Signature:……………….. Thumbprint 
Witness name:……………Date:………………. Signature …………… 
Name (Researcher): ……………Date: ………….. Signature: ……………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
